Variant NM_000492.4:c.350G>A
Name | NM_000492.4:c.350G>A |
Protein name | NP_000483.3:p.(Arg117His) |
Genomic name (hg19) | chr7:g.117171029G>A UCSC |
#Exon/intron | exon 4 |
Legacy Name | R117H |
Class | disease-causing |
Subclass | CFTR-RD-causing |
WT sequence | TATGACCCGGATAACAAGGAGGAAC G CTCTATCGCGATTTATCTAGGCATA |
Mutant sequence | TATGACCCGGATAACAAGGAGGAAC A CTCTATCGCGATTTATCTAGGCATA |
dbSNP rs78655421 |
Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
Sheppard et al, 1993 | 7680769 | ✓ | ✓ | ✓ | |||
Hammerle et al, 2001 | 11278813 | ✓ | ✓ | ✓ | |||
Van Goor et al, 2014 | 23891399 | ✓ | ✓ | ✓ | |||
Sosnay et al, 2013 | 23974870 | ✓ | ✓ | ||||
LaRusch et al, 2014 | 25033378 | ✓ | ✓ | ✓ | |||
Bergougnoux et al, 2015 | 25797027 | ✓ | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
5 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 216 |
---|---|
Asymptomatic compound heterozygote | 11 |
CF | 4 |
CFTR-RD | 144
|
Fetal bowel anomalies | 1 |
Pending | 3 |
Pending (NBS) | 52 |
Pending non-CF | 1 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
Pending (NBS) | 5566 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4616 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3135 | heterozygote | CF-causing - Trans |
Pending (NBS) | 2877 | heterozygote | |
Pending (NBS) | 4182 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4159 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4146 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4122 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4119 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4113 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4030 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4019 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4010 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4263 | heterozygote | CF-causing - Trans |
Pending (NBS) | 4555 | heterozygote | CF-causing- Undef |
Pending (NBS) | 4420 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 4410 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3982 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3909 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3905 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3478 | heterozygote | CF-causing - Trans VUS3- Undef |
Pending (NBS) | 3477 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3472 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3458 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3442 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3437 | heterozygote | CF-causing - Trans |
Pending (NBS) | 5573 | heterozygote | CF-causing - Trans |
Pending (NBS) | 5570 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3504 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3512 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3787 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3775 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3773 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3672 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3668 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3663 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3648 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3590 | heterozygote | CF-causing- Undef |
Pending (NBS) | 3579 | heterozygote | CF-causing- Undef |
Pending (NBS) | 944 | heterozygote | CF-causing - Trans |
Pending (NBS) | 785 | heterozygote | CF-causing - Trans |
Pending (NBS) | 769 | heterozygote | CFTR-RD-causing - Trans |
Pending (NBS) | 5254 | heterozygote | CF-causing - Trans |
Pending (NBS) | 644 | heterozygote | CF-causing - Trans |
Pending (NBS) | 52 | heterozygote | CF-causing - Trans |
Pending (NBS) | 2212 | heterozygote | varying clinical consequence- Undef |
Pending (NBS) | 2183 | heterozygote | CF-causing- Undef |
Pending (NBS) | 1514 | heterozygote | CF-causing - Trans |
Pending (NBS) | 1513 | heterozygote | CF-causing - Trans |
Pending (NBS) | 3667 | homozygote | c.350G>A - p.(Arg117His) - Trans |
Pending (NBS) | 4123 | homozygote | c.350G>A - p.(Arg117His) - Trans |
Pending (NBS) | 566 | homozygote | c.350G>A - p.(Arg117His) - Trans |
Pancreatitis | 4642 | heterozygote | CF-causing- Undef |
Pancreatitis | 5154 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 4743 | heterozygote | CF-causing- Undef |
Pancreatitis | 3163 | heterozygote | varying clinical consequence - Trans |
Pancreatitis | 2811 | heterozygote | |
Pancreatitis | 2591 | heterozygote | VUS3- Undef |
Pancreatitis | 2907 | heterozygote | |
Pancreatitis | 6188 | heterozygote | CF-causing - Trans |
Pancreatitis | 4318 | heterozygote | CFTR-RD-causing- Undef |
Pancreatitis | 4692 | heterozygote | varying clinical consequence- Undef |
Pancreatitis | 1961 | heterozygote | |
Pancreatitis | 5708 | heterozygote | CF-causing- Undef |
Pancreatitis | 5397 | heterozygote | CF-causing- Undef |
CBAVD | 3334 | heterozygote | varying clinical consequence - Trans |
CBAVD | 3331 | heterozygote | CF-causing - Trans |
CBAVD | 3321 | heterozygote | |
CBAVD | 3279 | heterozygote | CF-causing- Undef |
CBAVD | 3273 | heterozygote | CF-causing- Undef |
CBAVD | 3266 | heterozygote | CF-causing- Undef |
CBAVD | 3265 | heterozygote | CF-causing - Trans |
CBAVD | 3241 | heterozygote | CF-causing- Undef |
CBAVD | 3343 | heterozygote | CF-causing- Undef |
CBAVD | 3355 | heterozygote | CF-causing- Undef |
CBAVD | 3415 | heterozygote | CF-causing - Trans |
CBAVD | 3391 | heterozygote | CF-causing- Undef |
CBAVD | 4750 | heterozygote | CF-causing- Undef |
CBAVD | 3381 | heterozygote | varying clinical consequence- Undef |
CBAVD | 3374 | heterozygote | varying clinical consequence- Undef |
CBAVD | 3372 | heterozygote | CF-causing - Trans |
CBAVD | 3371 | heterozygote | CF-causing - Trans |
CBAVD | 2742 | heterozygote | CF-causing - Trans |
CBAVD | 2734 | heterozygote | CF-causing- Undef |
CBAVD | 2714 | heterozygote | CF-causing- Undef |
CBAVD | 2700 | heterozygote | CF-causing- Undef |
CBAVD | 2693 | heterozygote | CF-causing- Undef VUS3- Undef |
CBAVD | 2609 | heterozygote | VUS1- Undef |
CBAVD | 4929 | heterozygote | VUS3 - Cis varying clinical consequence - Trans |
CBAVD | 2885 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2481 | heterozygote | |
CBAVD | 4597 | heterozygote | varying clinical consequence- Undef |
CBAVD | 4576 | heterozygote | VUS3- Undef |
CBAVD | 4575 | heterozygote | CF-causing- Undef |
CBAVD | 4472 | heterozygote | CF-causing- Undef |
CBAVD | 5945 | heterozygote | CF-causing- Undef |
CBAVD | 5766 | heterozygote | varying clinical consequence - Trans |
CBAVD | 5281 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 1364 | heterozygote | CF-causing - Trans |
CBAVD | 931 | heterozygote | CF-causing - Trans |
CBAVD | 893 | heterozygote | CF-causing - Trans |
CBAVD | 832 | heterozygote | CF-causing - Trans |
CBAVD | 1362 | heterozygote | CF-causing - Trans |
CBAVD | 1361 | heterozygote | CF-causing - Trans |
CBAVD | 1347 | heterozygote | CF-causing - Trans |
CBAVD | 1341 | heterozygote | CF-causing - Trans |
CBAVD | 4850 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 1268 | heterozygote | CF-causing- Undef |
CBAVD | 1030 | heterozygote | varying clinical consequence- Undef |
CBAVD | 506 | heterozygote | CF-causing- Undef |
CBAVD | 479 | heterozygote | CF-causing- Undef |
CBAVD | 478 | heterozygote | CF-causing- Undef |
CBAVD | 438 | heterozygote | CF-causing - Trans |
CBAVD | 427 | heterozygote | CF-causing- Undef |
CBAVD | 409 | heterozygote | CF-causing- Undef |
CBAVD | 403 | heterozygote | VUS1 - Trans CF-causing - Trans |
CBAVD | 4724 | heterozygote | CF-causing- Undef |
CBAVD | 512 | heterozygote | CFTR-RD-causing - Trans |
CBAVD | 520 | heterozygote | CF-causing- Undef |
CBAVD | 728 | heterozygote | CF-causing- Undef |
CBAVD | 724 | heterozygote | CF-causing - Trans |
CBAVD | 721 | heterozygote | CF-causing - Trans |
CBAVD | 717 | heterozygote | CF-causing - Trans |
CBAVD | 675 | heterozygote | CF-causing- Undef |
CBAVD | 650 | heterozygote | CF-causing- Undef |
CBAVD | 640 | heterozygote | CF-causing- Undef |
CBAVD | 633 | heterozygote | CF-causing- Undef |
CBAVD | 1372 | heterozygote | CF-causing - Trans |
CBAVD | 5874 | heterozygote | VUS3- Undef |
CBAVD | 5665 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
CBAVD | 1893 | heterozygote | CF-causing- Undef |
CBAVD | 4979 | heterozygote | CF-causing- Undef |
CBAVD | 1979 | heterozygote | varying clinical consequence- Undef |
CBAVD | 2336 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 2263 | heterozygote | CF-causing- Undef |
CBAVD | 2208 | heterozygote | CF-causing- Undef |
CBAVD | 2025 | heterozygote | CF-causing- Undef |
CBAVD | 2004 | heterozygote | CF-causing- Undef |
CBAVD | 1774 | heterozygote | CF-causing- Undef |
CBAVD | 1745 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1439 | heterozygote | CF-causing - Trans |
CBAVD | 1437 | heterozygote | CF-causing - Trans |
CBAVD | 1435 | heterozygote | CF-causing - Trans |
CBAVD | 1433 | heterozygote | CF-causing - Trans |
CBAVD | 1430 | heterozygote | CF-causing - Trans |
CBAVD | 1429 | heterozygote | CF-causing - Trans |
CBAVD | 1425 | heterozygote | CF-causing - Trans |
CBAVD | 1419 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1397 | heterozygote | CF-causing - Trans |
CBAVD | 1394 | heterozygote | VUS3 - Trans |
CBAVD | 1393 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1378 | heterozygote | CF-causing - Trans |
CBAVD | 1467 | heterozygote | CF-causing - Trans |
CBAVD | 1470 | heterozygote | CF-causing - Trans |
CBAVD | 1475 | heterozygote | CF-causing - Trans |
CBAVD | 1504 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1496 | heterozygote | CF-causing - Trans |
CBAVD | 1482 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1480 | heterozygote | CF-causing - Trans |
CBAVD | 701 | homozygote | c.350G>A - p.(Arg117His) - Trans |
Asymptomatic compound heterozygote | 3019 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 5333 | heterozygote | non-CF - Trans |
Asymptomatic compound heterozygote | 4260 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
Asymptomatic compound heterozygote | 4259 | heterozygote | VUS3- Undef |
Asymptomatic compound heterozygote | 925 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 778 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 959 | heterozygote | VUS3 - Trans |
Asymptomatic compound heterozygote | 768 | heterozygote | CF-causing - Trans |
Asymptomatic compound heterozygote | 4955 | heterozygote | CFTR-RD-causing - Trans |
Asymptomatic compound heterozygote | 4736 | heterozygote | VUS3 - Trans |
Asymptomatic compound heterozygote | 2383 | heterozygote | CF-causing- Undef |
Fetal bowel anomalies | 621 | heterozygote | |
Bronchiectasis | 5005 | heterozygote | CF-causing- Undef |
Bronchiectasis | 2502 | heterozygote | CFTR-RD-causing- Undef VUS3- Undef |
Bronchiectasis | 2960 | heterozygote | |
Bronchiectasis | 3698 | heterozygote | CF-causing- Undef |
Bronchiectasis | 693 | heterozygote | CF-causing - Trans VUS1- Undef |
Bronchiectasis | 5000 | heterozygote | CF-causing - Trans |
Bronchiectasis | 2344 | heterozygote | |
Bronchiectasis | 2280 | heterozygote | CF-causing- Undef |
Other | 3246 | heterozygote | CF-causing - Trans |
Other | 3397 | heterozygote | CF-causing - Trans |
Other | 3233 | heterozygote | CF-causing - Trans |
Other | 3167 | heterozygote | CF-causing - Trans |
Other | 4927 | heterozygote | varying clinical consequence- Undef |
Other | 2829 | heterozygote | CF-causing - Trans |
Other | 2834 | heterozygote | CF-causing - Trans |
Other | 3141 | heterozygote | CF-causing - Trans |
Other | 2906 | heterozygote | varying clinical consequence - Trans |
Other | 2874 | heterozygote | CF-causing - Trans |
Other | 4292 | heterozygote | CF-causing - Trans |
Other | 4810 | heterozygote | CF-causing- Undef |
Other | 4801 | heterozygote | CF-causing- Undef |
Other | 5625 | heterozygote | CF-causing - Trans |
Other | 5567 | heterozygote | CF-causing - Trans |
Other | 877 | heterozygote | CF-causing - Trans |
Other | 815 | heterozygote | CF-causing - Trans |
Other | 789 | heterozygote | CF-causing- Undef |
Other | 983 | heterozygote | CF-causing - Trans |
Other | 1184 | heterozygote | varying clinical consequence- Undef |
Other | 1158 | heterozygote | CF-causing- Undef |
Other | 1141 | heterozygote | CF-causing- Undef |
Other | 752 | heterozygote | CF-causing - Trans |
Other | 5666 | heterozygote | VUS3- Undef |
Other | 1676 | heterozygote | CF-causing- Undef |
Other | 1640 | heterozygote | CF-causing- Undef VUS3- Undef |
Pending | 1544 | heterozygote | CF-causing - Trans |
Pending | 1990 | heterozygote | CF-causing- Undef |
Pending | 2428 | heterozygote | CF-causing- Undef |
CF | 4418 | heterozygote | CFTR-RD-causing - Cis CF-causing - Trans VUS3- Undef |
CF | 4973 | heterozygote | CF-causing- Undef |
CF | 2182 | heterozygote | CF-causing- Undef |
CF | 1562 | heterozygote | CF-causing - Trans |
Aquagenic palmoplantar keratoderma | 5702 | heterozygote | VUS3- Undef |
CRS-NP | 3088 | heterozygote | CF-causing - Trans |
Pending non-CF | 3094 | heterozygote | varying clinical consequence - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|